BNGO - Bionano Genomics, Inc.
IEX Last Trade
0.22
0.010 4.500%
Share volume: 42,299
Last Updated: Thu 26 Dec 2024 08:29:54 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$0.21
0.01
4.71%
Fundamental analysis
20%
Profitability
8%
Dept financing
11%
Liquidity
75%
Performance
20%
Performance
5 Days
0.35%
1 Month
-15.67%
3 Months
-54.15%
6 Months
-68.86%
1 Year
-89.73%
2 Year
-86.68%
Key data
Stock price
$0.22
DAY RANGE
$0.20 - $0.21
52 WEEK RANGE
$0.20 - $2.16
52 WEEK CHANGE
-$90.17
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Robert E. Holmlin
Region: US
Website: bionanogenomics.com
Employees: 300
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: bionanogenomics.com
Employees: 300
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping. NxClinical offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics.
Recent news